IP Library › Assignment 038371/0372
Patent Assignment
Reel/Frame 038371/0372

Assignment of Assignor's Interest

Recorded: 2016-04-25 Pages: 10
Assignors
NERING, RACHEL C.
Executed: 2016-04-21
WANG, HONGFANG
Executed: 2016-04-21
Assignee
MERRIMACK PHARMACEUTICALS, INC.
ONE KENDALL SQUARE, SUITE B7201, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Properties (2)
Methods of Treating Patients Having Mutations in the Extracellular Domain of Epidermal Growth Factor Receptor (Egfr) with a Combination of Three Fully Human Monoclonal Anti-Egfr Antibodies
Application: 62/308,697 →
Methods of Treating Patients Having Mutations in the Extracellular Domain of Epidermal Growth Factor Receptor (Egfr) with a Combination of Three Fully Human Monoclonal Anti-Egfr Antibodies
Application: 62/323,475 →
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 25, 2016
From: KEARNS, JEFFREY D.; WOLF, BENI B.
To: MERRIMACK PHARMACEUTICALS, INC.
Reel/Frame 038371/0286 →
Assignment of Assignor's Interest Apr 25, 2016
From: ARENA, SABRINA; BARDELLI, ALBERTO
To: MERRIMACK PHARMACEUTICALS, INC.
Reel/Frame 038371/0471 →